Bill Ackman revealed that Pershing Square Holdings received a request for cooperation from a Senate Committee conducting an investigation on the pricing of off-patent drugs. In a letter and annual report to shareholders, Ackman said his firm will fully cooperate with the U.S. Senate Special Committee on Aging, which is seeking to have an understanding of the pharmaceutical industry and related regulatory and public policy concerns. The Special Committee started an investigation due to the sudden and significant increase in drug prices last year. Some of the pharmaceutical companies under…
Read MoreAckman: Pershing Square to Cooperate with Senate’s Probe on Drug Pricing
